Schneiderman Prelims Vol-I. qxd

90
A CLINICIAN
’
S GUIDE TO DERMATOLOGIC DIFFERENTIAL DIAGNOSIS, VOLUME 1
Schneiderman page 1-100.qxd 5/16/2006 6:49 PM Page 90

---

Cinnarizine – lichen planus pemphigoides-like eruption 
BJD
112:607–613, 1985
Cyclosporine – pseudo-porphyria cutanea tarda 
AD
139:1373–1374, 2003
Dilantin
Dipyrone-induced pemphigus
Drug-induced thrombocytopenia – oral hemorrhagic bullae 
Cutis
62:193–195, 1998
Enoxaparin sodium (low molecular weight heparin)-induced
bullous pemphigoid 
JAAD 51:141–142, 2004
Epsilon amino caproic acid infusion 
JAAD 27:880–882, 1992
Estrogen dermatitis – papulovesicular 
JAAD 32:25–31, 1995
Extravasation from intravenous infusion
Fixed drug eruption 
Rook p.3367, 1998, Sixth Edition
Furosemide – phototoxic blisters 
BJD 94:495–499, 1976
Ibuprofen-induced bullous pemphigoid 
JAAD 19:91–94, 1988
Interleukin-2 reaction 
AD 130:890–893, 1994
Iododerma – vesicular 
JAAD 36:1014–1016, 1997; bullous
Australas J Dermatol 28:119–122, 1987
Jarisch–Herxheimer reaction – vesicular; treatment of syphilis,
onchocerciasis, Lyme disease, strongyloidiasis 
AD 125:77–81,
1989; Hautarzt 35:588–590, 1984
Leuprolide – dermatitis herpetiformis 
Cutis 75:49–52, 2005
Linear IgA disease
Drug-induced 
JAAD 42:316–323, 2000; JAAD 32:296, 1995
Acetaminophen 
JAAD 48:289–300, 2003
Amiodarone 
JAAD 31:809–811, 1994
Ampicillin
Atorvastatin 
JAAD 44:696–699, 2001
Captopril 
Cutis 44:393–396, 1989; JAAD 38:352–356, 1998
Carbamazepine 
JAAD 46:S32–33, 2002
Cefamandole 
JAAD 48:289–300, 2003; JAAD 38:352–356,
1998
Cyclosporine 
JAAD 42:316–323, 2000
Diclophenac 
JAAD 26:45–48, 1992; AD
124:1186–1188, 1988
Glibenclamide 
AD 123:1121–1122, 1987
Interferon-
α
, 
γ
JAAD 42:316–323, 2000
Interleukin-2
Iodine contrast agent
Lithium carbonate 
AD 124:1186–1188, 1988; JAAD
26:45–48, 1992
Penicillin G potassium 
JAAD 42:316–323, 2000
Phenytoin 
JAAD 38:352–356, 1998
Polychemotherapy 
JAAD 38:352–356, 1998
PUVA 
Ghatan p.230, 2002, Second Edition
Somatostatin 
JAAD 38:352–356, 1998
Sulfisoxazole 
JAAD 38:352–356, 1998
Vancomycin 
JAAD 26:45–48, 1992
Vigabatrin 
JAAD 42:316–323, 2000
Methotrexate and leucovorin (palms and soles)
AD 123:990–992, 1987
Nalidixic acid – UVA; bullous photoreaction 
Am J Med
58:576–580, 1975
Pegfilgastrim – giant bullae; bullous Sweet’s syndrome due to
pegfilgastrim (pegylated G-CSF) 
JAAD 52:901–905, 2005
Pemphigus vegetans due to captopril 
JAAD 27:281–284, 1992
Pemphigus – drug-induced
JAAD 39:876–878, 1998; JAAD
26:364–366, 1992; JAAD 30:651–653, 1994
Antibiotics
Ampicillin
Cephalexin
Cefadroxil
Ceftazidine
Ethambutol
INH
Nalidixic acid
Penicillin
Rifampin
Pyrazalon derivatives
Aminophenazone
Aminopyrine
Azapropazone
Oxyphenylbutazone
Phenylbutazone
Sulfur-containing drugs
Captopril
Enalapril
Gold (aurothioglucose) 
Mercaptopropionylglycine
Penicillamine
Pyritinol
Sulfasalazine
Tetanus and diphtheria vaccine with a thiol preservative
BJD 147:188–189, 2002
Thiamazole
Thiopronine
5-thiopyridoxine
Miscellaneous
Aspirin
Benzoin
5-fluorouracil (topical) 
Furosemide
Glibenclamide
Heroin
Hydantoin
Ibuprofen
Indomethacin
Interleukin-2 and 
β
-interferon
Levodopa
Lysine acetylsalicylate
Meprobamate
Nifedipine
Phenacetin
Phenobarbital
Phenylbutene
Piroxicam
Practalol
Progesterone
Propranolol
Pyritinol
PUVA
Thermal burns
Tincture of benzoin
Penicillamine 
AD 128:977–982, 1992; penicillamine-induced
pemphigus vulgaris or foliaceus 
JAAD 37:121–123, 1997;
AD 128:977–981, 1992; JAAD 6:317–324, 1982; Am J
Dermatopathol 3:85–92, 1981; bullous pemphigoid-like eruption
AD 123:1119–1120, 1987; JAAD 8:548–550, 1983; EBA-like
bullae in chronic GVH disease 
JAAD 49:1157–1159, 2003
Penicillin-induced bullous pemphigoid mimicking erythema
multiforme 
JAAD 18:345–349, 1988
Phenacetin-induced bullous pemphigoid-like eruption
AD 120:1196–1199, 1984
Phlebogram dye – toxic reaction
Piroxicam photodermatitis
PPD reaction
Pseudo-porphyria cutanea tarda 
JAAD 44:100–108, 2001;
JAAD 33:551–573, 1995; JAAD 31:500, 1994
Drug-induced
Acetretin 
JAAD 53:169–171, 2005